Cite
HARVARD Citation
Azuri, J. et al. (2023). Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis. Diabetes, obesity & metabolism. 25 (4), pp. 961-964. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Azuri, J. et al. (2023). Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis. Diabetes, obesity & metabolism. 25 (4), pp. 961-964. [Online].